PHIA Koninklijke Philips N.V.

Philips recognized in Gartner’s 2020 Market Guide for Virtual Care Solutions

Philips recognized in Gartner’s 2020 Market Guide for Virtual Care Solutions

November 5, 2020

The ability to support the delivery of virtual care is now a must-have capability for all healthcare delivery organizations identified in report

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has been identified as a Representative Vendor in the Gartner "Market Guide for Virtual Care Solutions" report [1]. The report underscores that “virtual care solutions enable healthcare delivery organizations to provide high-quality, cost-effective clinical care at a distance.” Such solutions help seamlessly drive clinical and operational efficiencies by empowering clinicians with key patient data to enhance decision-making.

“We are pleased that Gartner has recognized Philips as a Representative Vendor for its enterprise virtual care portfolio and telehealth portfolio in their recent Market Guide,” said Roy Jakobs, Chief Business Leader Connected Care at Royal Philips. “Virtual care has empowered clinicians to meet patient needs, even during COVID-19. By strategically partnering with our customers, Philips is helping health systems build programs to address the immediate demands of the pandemic, while also building sustainable and scalable systems that will extend beyond COVID-19 to enable the right care anywhere, anytime.”

In its report, Gartner identified five critical capabilities for virtual care solutions – (a) clinician experience, (b) patient experience, (c) artificial intelligence, (d) information capture for billing and reporting, and (e) modular, open solutions. Philips was included as a Representative Vendor based on its telehealth and virtual care solutions. Moreover, Philips aims to meet healthcare providers’ needs through its platform-based virtual care approach to help deliver on the quadruple aim of care: improving health outcomes and lowering the cost of care, while also improving the patient and care provider experience.

More information on Philips’ enterprise telehealth solutions portfolio can be accessed .

The Gartner Market Guide on Virtual Care can be accessed .

[1] Gartner, “Market Guide for Virtual Care Solutions”, Sharon Hakkennes, Pooja Singh, 26 October 2020.

Gartner Disclaimer: Gartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

For further information, please contact:

Anna Hogrebe

Philips Global Press Office

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at .



 

Attachment

EN
05/11/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips intends to extend maturity of forward purchases of 4 million s...

Philips intends to extend maturity of forward purchases of 4 million shares for long-term incentive plans September 15, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA) announces today that it intends to extend the settlement of two forward contracts for 2 million long-term incentive plans shares each as part of the share repurchase program on June 14, 2023. The planned extension will postpone the original maturity dates in Q4 2025 by one year to a new maturity date in Q4 2026. Further details will be available via this . For further information, please contact:Michael FuchsPhil...

 PRESS RELEASE

Philips and Masimo announce innovation partnership to advance access t...

Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies September 11, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, and (NASDAQ: MASI) today announced that the two companies have renewed their multi-year strategic collaboration, marking a fresh chapter in their long-standing partnership. With a shared commitment to innovation and expanding access to high-quality, connected care, the two companies are taking a bold new approach in accelerating the development and delivery of next-...

 PRESS RELEASE

Philips launches smart telemetry platform for cardiac monitoring that ...

Philips launches smart telemetry platform for cardiac monitoring that provides continuous, enterprise-wide connectivity beyond the bedside September 4, 2025 Empowering clinical teams to respond to surges, track usage and ease workflows with user-friendly touchscreen technology for telemetry patients on the move Cambridge, Massachusetts – , a global leader in health technology, today announced the introduction of an  designed to help address critical challenges in healthcare – including staff shortages and alarm management. A key component of the solution is the next-generation Telemetry M...

 PRESS RELEASE

Philips launches Transcend Plus for EPIQ CVx and Affiniti CVx, deliver...

Philips launches Transcend Plus for EPIQ CVx and Affiniti CVx, delivering breakthrough image quality and FDA-cleared AI enhancements in cardiovascular ultrasound August 27, 2025  Next-generation 2D and 3D imaging and intelligent automation empower clinicians to make faster, more confident decisions in cardiac care Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the release of Transcend Plus, the next generation its EPIQ CVx and Affiniti CVx cardiovascular ultrasound systems. Transcend Plus delivers major advancements in image qua...

Marc Hesselink ... (+3)
  • Marc Hesselink
  • CFA
  • Thymen Rundberg

Philips/Volatile results/HOLD

Philips reported a better-than-expected 2Q25 update. We increase our target price to €23 per share (from €21) but keep our Hold rating. The results are surprisingly volatile in our view with large quarterly fluctuations. We believe valuation is fair relative to peers given its lower growth and margin profile.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch